A Biotech Gem With 11.25% Upside Potential
Investors with an eye on the biotechnology sector may find Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) an intriguing prospect. With a […]
February 17, 2026
eToro crypto revenue surges to $13bn as traders switch to commodities – DL News
eToro stocks surged on Tuesday. This came despite a slide in revenue from crypto trading in the last quarter. The
A 190% Potential Upside Awaits Investors
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a pioneering biopharmaceutical company, stands at the forefront of developing therapies for rare and ultra-rare
RWAs Show Strength with 13% Gain Despite Crypto Sell-Off
16h05 â–ª 4 min read â–ª by Ifeoluwa O. Summarize this article with: ChatGPTPerplexityGrok Over the past month, tokenized real-world
Potential 100% Upside Amidst Challenging Financials
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) operates at the cutting edge of biotechnology, merging biology and chemistry with advanced data science
Why the 10/10 Crypto Crash Still Haunts Bitcoin
Four months ago, digital assets underwent what I believe was the most consequential liquidation event in their history. On October
Banking giant updates Nvidia stock price targetÂ
Citigroup has reaffirmed its bullish stance on Nvidia (NASDAQ: NVDA), expecting the semiconductor giant to outperform later this year. The
Is the Netherlands Taxing Unrealized Crypto Gains? It’s Complicated
In brief From January 2028, taxation in the Netherlands will be applied to actual annual returns, including unrealized crypto gains,
Evaluating A 25% Upside Potential In The Biotech Sector
Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a key player in the biotechnology sector, is capturing investor attention with its promising pipeline
Crypto market wavers, Fed official predicts more rate cuts
The crypto market wavered today, February 17, as traders watched several potential catalysts, including Federal Reserve statements and the happenings